Teva Pharmaceutical Profile


Odds of Distress

Equity ratings for Teva Pharmaceutical Industries are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 12, 2019 and ending today December 11, 2019. Click here to learn more.

Teva Pharmaceutical Profile

The stock is undergoing above average trading activities. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. Teva Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 42535 people. more
NameTeva Pharmaceutical Industries
CEOCarlo NotaristefaniView All
Thematic Classifications
Active Investing Ideas
    Israel Wall Street
Analyst Consensus
Macroaxis Advice
Bond Rating
InstrumentUSA Stock View All
Business Address5 Basel Street
Foreign Associates
ExchangeBATS Exchange
IndustryDrug Manufacturers?Specialty & Generic
Phone972 3 914 8171
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Teva Pharmaceutical Industries (TEVA) is traded on BATS Exchange in USA and employs 42,535 people. The company currently falls under 'Large-Cap' category with current market capitalization of 10.74 B. Teva Pharmaceutical conducts business under Healthcare sector and is part of Drug Manufacturers?Specialty & Generic industry. The entity has 1.09 B outstanding shares of which 64.82 M shares are at this time shorted by private and institutional investors with about 2.61 trading days to cover. TEVA PHARM INDS A currently holds about 1.24 B in cash with 1.72 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.14.
Check Teva Pharmaceutical Probability Of Bankruptcy

Ownership Allocation (%)

Teva Pharmaceutical Target Price Odds Analysis

Odds Below 9.56HorizonTargetOdds Above 9.56
80.89%30 days 9.56 19.03%
Based on normal probability distribution, the odds of Teva Pharmaceutical to move above current price in 30 days from now is about 19.03 (This Teva Pharmaceutical Industries probability density function shows the probability of Teva Pharmaceutical Stock to fall within a particular range of prices over 30 days) .

Teva Pharmaceutical Top Holders

Teva Pharmaceutical Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Capital Research Global InvestorsCommon Shares130.9 M900.8 M
Wellington Management Group LlpCommon Shares76 M522.8 M
Melvin Capital Management LpPut Options12.4 M85.2 M
Allianz Asset Management GmbhDebt54.5 M49.8 M
Jpmorgan Chase CoCall Options7.2 M49.2 M
View Teva Pharmaceutical Diagnostics

Teva Pharmaceutical Risk Profiles

Teva Pharmaceutical Key Fundamentals

Teva Pharmaceutical Against Markets

Did you try this?

Run Portfolio Manager Now


Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Teva Pharmaceutical Upcoming and Recent Events

Teva Pharmaceutical Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMay 8, 2017
Next Earnings ReportAugust 3, 2017
Next Fiscal Quarter EndMarch 31, 2017
Next Fiscal Year EndFebruary 12, 2018
Last Quarter Report DateDecember 31, 2016
Last Earning Anouncement DateMarch 31, 2016

Teva Pharmaceutical Corporate Filings

Teva Pharmaceutical SEC Reporting

Unclassified Corporate Event

Teva Pharmaceutical Corporate Directors

Nechemia Peres Independent Director
Moshe Many Independent Director
Roger Abravanel Independent Director
Also please take a look at World Market Map. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.